(Q63337804)

English

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Comparison Between Alpha Blocker Monotherapy and 5-alpha-reductase Inhibitor Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (English)

0 references

medical condition

hyperplasia

0 references

start time

January 2011

0 references

end time

October 2015

0 references

number of participants

315

0 references

research intervention

5-alpha-reductase inhibitors

0 references

clinical trial phase

phase IV clinical trial

0 references

research site

Samsung Medical Center

0 references

minimum age

45 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01301599

0 references

(Q63337804)

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)